The Swiss Times - Swiss News in English

Swiss Biotech Firm Idorsia: Stock Soars – but Why?

  • By The Swiss Times
  • 26 February 2024

Idorsia’s Surging Stock: Speculations Amid Silence

Swiss Biotech Firm Idorsia: Stock Soars – but Why?
Keystone/SDA – GEORGIOS KEFALAS

Swiss biotech firm Idorsia, based in Basel, has seen a spike in stock prices from just $2.25 a share to over $3.25, its highest point being Monday morning.

Swiss Biotech Firm Idorsia: Stock Soars – but Why?
Idorsia Stock Price: Yahoo Finance

The Swiss biotech firm is working on a range of products for fighting insomnia, Fabry disease, resistant hypertension, suspected acute myocardial infarction, and more. The Swiss biotech firm employs over 800 people and is a large player in the space.

What has caused the dramatic rise in stock price over the weekend and into Monday morning? Their last official press release was over a month ago, surrounding the delay of their 2023 full-year financial results and the hopes for securing more funding in 2024 at a J.P. Morgan conference.

With this news being anything but riveting and the sudden spike in price, it may be reasonable to assume that the firm has secured its hoped funding. However, there could be other contributing factors: FDA approval may have come through, or the scope of sales for specific drugs have expanded across Canada, the USA, and Europe as they hoped.

Last year the company created 10 million treasury shares, is this a signal they are looking to go private, exiting the open market? Do they have excess cash reserves?

No news is coming from Idorsia being officially announced, so we are left wondering what is next for the Swiss biotech firm. Have they achieved more funding? Is this a result of internal information or pure speculation? We could not verify any further approvals on the FDA website, and so, for the time being, we are left in the dark as to what has caused this spike.

Most Read

Sunday, April 7 – Round Up

7 April 2024
Sunday, April 7 – Round Up
Switzerland may fund French nuclear projects as it grapples with internal issues in the news this Sunday morning.

Swiss Employers Association: Increase Retirement Ages

8 April 2024
Swiss Employers Association: Increase Retirement Ages
Following the rejection of a pension initiative, the Swiss Employers' Association (SAV) recommends a gradual raise in retirement age to 66.

Diehl Defence Will Develop Drones For Swiss Defence Firm Skysec

12 April 2024
Diehl Defence Will Develop Drones For Swiss Defence Firm Skysec
Diehl Defence collaborates with Skysec Defence under a new agreement to enhance drone defense capabilities for military use.

Zurich VC Lakestar Secures $600 Million In New Funds

12 April 2024
Zurich VC Lakestar Secures $600 Million In New Funds
Lakestar successfully closes two new funds, accumulating $600 million, to advance Europe's digital sovereignty.

Stay in Touch!

Noteworthy

Thai Central Group to Allegedly Takeover KaDeWe
Thai Central Group to Allegedly Takeover KaDeWe
12 April 2024
Leonteq and Raiffeisen Extend Partnership
Leonteq and Raiffeisen Extend Partnership
12 April 2024